Design and synthesis of a new, conformationally constrained, macrocyclic small-molecule inhibitor of STAT3 via ‘click chemistry’

https://doi.org/10.1016/j.bmcl.2007.04.096Get rights and content

Abstract

STAT3 is a promising molecular target for the design of new anticancer drugs. In this paper, we report the design and synthesis of a conformationally constrained macrocyclic peptidomimetic 2 via click chemistry. Compound 2 was determined to bind to STAT3 with a Ki value of 7.3 μM in a competitive fluorescence-polarization-based binding assay, representing a promising initial lead compound for further optimization.

References and notes (13)

  • J.F. Bromberg et al.

    Cell

    (1999)
  • Z. Ren et al.

    Bioorg. Med. Chem. Lett.

    (2003)
  • J. Schust et al.

    Chem. Biol.

    (2006)
  • J. Schust et al.

    Anal. Biochem.

    (2004)
  • J.E. Darnell

    Nat. Rev. Cancer

    (2002)
  • H. Yu et al.

    Nat. Rev. Cancer

    (2004)
There are more references available in the full text version of this article.

Cited by (0)

View full text